Global Medical Financials
This page shows Global Medical (GMRE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Cash generation stays sturdier than accounting profit because this asset-heavy balance sheet carries large non-cash charges and financing costs.
FY2025 shows the core mismatch clearly: a-$6.9M net loss alongside$73.6M of operating cash flow. Because depreciation remained large at about$58.0M and interest expense kept rising to$31.8M , reported earnings now understate the cash the existing asset base is still producing.
Across FY2021-FY2025, revenue increased from
The balance sheet is not cash-rich: year-end cash was only
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Global Medical's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Global Medical's revenue grew 6.8% year-over-year to $148.2M, a solid pace of expansion. This earns a growth score of 38/100.
Global Medical carries a low D/E ratio of 0.00, meaning only $0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
Global Medical generates a -1.4% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 12/100. This is down from 1.3% the prior year.
Global Medical passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Global Medical generates $-10.69 in operating cash flow ($73.6M OCF vs -$6.9M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Key Financial Metrics
Earnings & Revenue
Global Medical generated $148.2M in revenue in fiscal year 2025. This represents an increase of 6.8% from the prior year.
Global Medical reported -$6.9M in net income in fiscal year 2025. This represents a decrease of 202.9% from the prior year.
Global Medical earned $-0.91 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 1616.7% from the prior year.
Cash & Balance Sheet
Global Medical held $9.1M in cash against $1.2M in long-term debt as of fiscal year 2025.
Global Medical had 13M shares outstanding in fiscal year 2025. This represents a decrease of 1.0% from the prior year.
Margins & Returns
Global Medical's net profit margin was -4.6% in fiscal year 2025, showing the share of revenue converted to profit. This is down 9.5 percentage points from the prior year.
Global Medical's ROE was -1.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 2.6 percentage points from the prior year.
Capital Allocation
Global Medical spent $6.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.
GMRE Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $38.1M-0.9% | $38.4M+3.1% | $37.2M-1.9% | $38.0M+9.7% | $34.6M-1.5% | $35.2M+2.6% | $34.3M+0.1% | $34.2M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $5.1M-7.4% | $5.5M+13.0% | $4.9M-19.3% | $6.0M+66.4% | $3.6M-53.0% | $7.7M+75.9% | $4.4M-4.5% | $4.6M |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | $7.2M-13.9% | $8.4M+2.8% | $8.2M+2.1% | $8.0M+11.7% | $7.2M-5.3% | $7.6M+4.6% | $7.2M+3.5% | $7.0M |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | $1.7M+126.9% | -$6.1M-21.5% | -$5.1M-964.6% | $585K-84.3% | $3.7M+27.2% | $2.9M-13.3% | $3.4M+273.7% | -$2.0M |
| EPS (Diluted) | $-0.06 | N/A | $-0.45 | $-0.01-106.3% | $0.16 | N/A | $0.14+380.0% | $-0.05 |
GMRE Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.2B-0.4% | $1.2B-2.4% | $1.3B-1.8% | $1.3B+2.2% | $1.3B+1.0% | $1.3B+1.1% | $1.2B+0.1% | $1.2B |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $8.2M-9.9% | $9.1M+27.5% | $7.1M+8.3% | $6.6M+21.6% | $5.4M-20.6% | $6.8M+19.1% | $5.7M+15.0% | $5.0M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $6.8M-5.9% | $7.2M-9.1% | $7.9M+1.5% | $7.8M-3.4% | $8.1M+9.2% | $7.4M-8.6% | $8.1M+0.6% | $8.1M |
| Goodwill | $5.9M0.0% | $5.9M0.0% | $5.9M0.0% | $5.9M0.0% | $5.9M0.0% | $5.9M0.0% | $5.9M0.0% | $5.9M |
| Total Liabilities | $717.4M+0.7% | $712.4M-7.2% | $767.4M-0.6% | $771.9M+5.5% | $731.5M+4.4% | $700.6M+3.3% | $678.0M+2.3% | $662.8M |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | N/A | $1.2M0.0% | $1.2M-91.9% | $14.2M-0.7% | $14.3M-1.1% | $14.4M-0.7% | $14.5M-1.0% | $14.7M |
| Total Equity | $500.2M-1.9% | $509.8M+5.0% | $485.3M-3.6% | $503.2M-2.7% | $517.4M-3.1% | $534.1M-1.6% | $542.6M-2.5% | $556.4M |
| Retained Earnings | -$360.6M-3.1% | -$350.0M-5.2% | -$332.6M-5.1% | -$316.5M-3.5% | -$305.7M-4.1% | -$293.7M-4.5% | -$281.1M-4.5% | -$268.9M |
GMRE Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $13.4M-38.3% | $21.6M+23.2% | $17.6M-20.7% | $22.1M+80.4% | $12.3M-40.2% | $20.5M+25.9% | $16.3M-13.9% | $18.9M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$9.8M-245.9% | $6.7M+1059.9% | -$703K+98.2% | -$39.2M-44.1% | -$27.2M-39.4% | -$19.5M+23.4% | -$25.5M-1527.9% | $1.8M |
| Financing Cash Flow | -$4.4M+83.1% | -$26.3M-62.1% | -$16.2M-186.8% | $18.7M+37.7% | $13.6M+8787.6% | $153K-98.3% | $9.2M+144.2% | -$20.7M |
| Dividends Paid | $10.9M+651.3% | $1.5M+0.1% | $1.5M-0.1% | $1.5M+0.1% | $1.5M-0.1% | $1.5M+0.1% | $1.5M-0.1% | $1.5M |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
GMRE Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | 4.3%+20.4pp | -16.0%-2.4pp | -13.6%-15.1pp | 1.5%-9.3pp | 10.8%+2.4pp | 8.4%-1.5pp | 9.9%+15.6pp | -5.7% |
| Return on Equity | 0.3%+1.5pp | -1.2%-0.2pp | -1.0%-1.2pp | 0.1%-0.6pp | 0.7%+0.2pp | 0.5%-0.1pp | 0.6%+1.0pp | -0.4% |
| Return on Assets | 0.1%+0.6pp | -0.5%-0.1pp | -0.4%-0.5pp | 0.1%-0.2pp | 0.3%+0.1pp | 0.2%-0.0pp | 0.3%+0.4pp | -0.2% |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 1.43+1.4 | 0.000.0 | 0.00-0.0 | 0.030.0 | 0.030.0 | 0.030.0 | 0.030.0 | 0.03 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
What is Global Medical's annual revenue?
Global Medical (GMRE) reported $148.2M in total revenue for fiscal year 2025. This represents a 6.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Global Medical's revenue growing?
Global Medical (GMRE) revenue grew by 6.8% year-over-year, from $138.8M to $148.2M in fiscal year 2025.
Is Global Medical profitable?
No, Global Medical (GMRE) reported a net income of -$6.9M in fiscal year 2025, with a net profit margin of -4.6%.
How much debt does Global Medical have?
As of fiscal year 2025, Global Medical (GMRE) had $9.1M in cash and equivalents against $1.2M in long-term debt.
What is Global Medical's net profit margin?
Global Medical (GMRE) had a net profit margin of -4.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Global Medical's return on equity (ROE)?
Global Medical (GMRE) has a return on equity of -1.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Global Medical's operating cash flow?
Global Medical (GMRE) generated $73.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Global Medical's total assets?
Global Medical (GMRE) had $1.2B in total assets as of fiscal year 2025, including both current and long-term assets.
What is Global Medical's debt-to-equity ratio?
Global Medical (GMRE) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Global Medical's return on assets (ROA)?
Global Medical (GMRE) had a return on assets of -0.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Global Medical's Piotroski F-Score?
Global Medical (GMRE) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Global Medical's earnings high quality?
Global Medical (GMRE) has an earnings quality ratio of -10.69x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Global Medical?
Global Medical (GMRE) scores 25 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.